SINGAPORE, Sept. 26, 2025 /PRNewswire/ — The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded from September 24-26, 2025. The conference brought together leading biopharmaceutical companies […]
SINGAPORE, Sept. 26, 2025 /PRNewswire/ — The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded from September 24-26, 2025. The conference brought together leading biopharmaceutical companies […]
SHANGHAI, Feb. 25, 2025 /PRNewswire/ — WuXi XDC Cayman Inc. (“WuXi XDC”, or the “Company”, stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, […]
